PEOPLE ON THE MOVE
Synteract
Synteract has announced Jack Shannon as the company’s new chief commercial officer.
Shannon joins the company from Chiltern, where he was vice president, Global Business Development Biopharma. He has also held roles at PRA Health Sciences and Quintiles, now IQVIA.
In his new role at Synteract, Shannon will oversee global sales and marketing functions.
“I am excited about this next chapter at Synteract, as we continue to build on positive momentum with the goal of bringing treatments to patients who need them,” he told us.
“I am eager to work with our clients, global sales and marketing teams, as well as our executive team to drive growth in market share and continue the success of the organization,” he said.